Moderna Cuts Outlook Amid Covid-Vaccine Supply Hurdles

Name Art / 03/11/2022 / Business News

[ad_1]

The pharmaceutical company says its sales could be as much as $3 billion lower this year than initially expected.

[ad_2]

Source link

Source link

Rate this post

Category Business News Tag Biotechnology C&E Industry News Filter Content Types corporate Corporate/Industrial News CovidVaccine Cuts Earnings Earnings Projections epidemics Factiva Filters Financial Performance general news health healthcare Healthcare/Life Sciences Hurdles Immunizations industrial news Infectious Diseases life sciences Medical Conditions medical treatments Medical Treatments/Procedures medications Merck & Moderna MRK MRNA Novel Coronaviruses outbreaks Outbreaks/Epidemics outlook PFE Pfizer Pharmaceuticals political Political/General News procedures Respiratory Tract Diseases Sales Figures specialized drugs Specialized Drugs/Medications Stéphane Bancel Supply SYND Vaccines WSJ-PRO-WSJ.com wsjhealth

Add your comment Cancel Reply

You must be logged in to post a comment.

Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.